This was measured in terms of the primary and secondary tumor growth, composition of infiltrating immune cells in the primary tumor, EMT gene signature, and expression of co-stimulatory molecules as well as intra-tumoral interferon gamma expression, indicative of intra-tumoral effector T cell functionality. The gene discussed is IFNG; the disease is neoplasm.